Finance

Lists
Why is TNYA down ६.७८%?
Dive Deeper
TNYA:NASDAQ
Tenaya Therapeutics Inc
US$ ०.३८
-६.७८%
(-०.०२८) 1D
US$ ०.३८
-०.१८% (-०.०००७०)
After hours
Closed: अक्टोबर १६, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNYA...
Open
US$ ०.४१
High
US$ ०.४२
Low
US$ ०.३७
Mkt. cap
८.५५ करोड
Avg. vol.
३४.२१ लाख
Volume
६७.४५ लाख
52-wk high
US$ २.०२
52-wk low
US$ ०.३६
EPS
-US$ ०.५३
Beta
२.८७
Shares outstanding
२२.४२ करोड
No. of employees
७०
Open
US$ ०.४१
High
US$ ०.४२
Low
US$ ०.३७
Mkt. cap
८.५५ करोड
Avg. vol.
३४.२१ लाख
Volume
६७.४५ लाख
52-wk high
US$ २.०२
52-wk low
US$ ०.३६
EPS
-US$ ०.५३
Beta
२.८७
Shares outstanding
२२.४२ करोड
No. of employees
७०
News stories
From web sources and news partners
About Tenaya Therapeutics Inc
CEO-
Employees७०
Founded२०१६
HeadquartersSouth San Francisco, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to TNYA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TNYA in the last 3 months.
Highest
Current US$ ०.३८
US$ ४०.०० (+१०,४०६.९६%)
Average
US$ १३.०० (+३,३१४.७६%)
Lowest
US$ ३.०० (+६८८.०२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
US$ ३.००
+६८८%
10/05/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
US$ ५.००
+१,२१३.४%
08/06/2026
Cory Jubinville, PhD
LifeSci Capital
Buy
Maintained
US$ ४.००
+९५०.७%
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$ ४०.००
+१०,४०७%
08/06/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/06/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
07/29/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
US$ २.००
+४२५.३%
06/03/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
US$ ८.००
+२,००१.४%
05/15/2026
Last report
२०२६ अगस्ट ५
Fiscal period
Q2 2026
-US$ ०.०९ / -US$ ०.०७
-३५.९०%miss
Revenue / Est. (USD)
११.१० लाख / १.०० करोड
-८८.९०%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
२.२५ लाख
११.१० लाख
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.५४ करोड
१.४८ करोड
१.४८ करोड
१.६६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५५.७३ लाख
५९.७७ लाख
५४.४७ लाख
५४.०६ लाख
Operating expense
२.०९ करोड
२.०८ करोड
२.०३ करोड
२.२० करोड
Total operating expenses
२.०९ करोड
२.०८ करोड
२.०३ करोड
२.२० करोड
Operating income
-२.०९ करोड
-२.०८ करोड
-२.०१ करोड
-२.०९ करोड
Other non operating income
३.०० हजार
२५.०० हजार
-
-१३.७० लाख
EBT including unusual items
-२.०३ करोड
-२.०२ करोड
-१.९३ करोड
-४.३४ करोड
EBT excluding unusual items
-२.०३ करोड
-२.०२ करोड
-१.९३ करोड
-२.१६ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.०३ करोड
-२.०२ करोड
-१.९३ करोड
-४.३४ करोड
Net profit margin
-
-
-८,५६५.३३%
-३,९०९.२८%
Earnings per share
-०.१२
-०.१२
-०.०९
-०.०९
Interest and investment income
६.५८ लाख
५.७५ लाख
७.९३ लाख
६.९७ लाख
Interest expense
-
-
-
-
Net interest expenses
६.५८ लाख
५.७५ लाख
७.९३ लाख
६.९७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.९१ करोड
-१.८९ करोड
-१.८३ करोड
-१.९२ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू